Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("AJANI, Jaffer A")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 221

  • Page / 9
Export

Selection :

  • and

Gemcitabine (Gemzar) in genitourinary and pancreatic cancerAJANI, Jaffer A.Seminars in oncology. 2002, Vol 29, Num 1, issn 0093-7754, 46 p., SUP3Serial Issue

The role of docetaxel in gastric cancerAJANI, Jaffer A.European journal of cancer. Supplement (1990). 2006, Vol 4, Num 10, pp 4-9, issn 1359-6349, 6 p.Conference Paper

Optimizing Docetaxel Chemotherapy in Patients With Cancer of the Gastric and Gastroesophageal Junction : Evolution of the Docetaxel, Cisplatin, and 5-fluorouracil RegimenAJANI, Jaffer A.Cancer. 2008, Vol 113, Num 5, pp 945-955, issn 0008-543X, 11 p.Article

The Area Between the Curves Gets No Respect : Is It Because of the Median Madness?AJANI, Jaffer A.Journal of clinical oncology. 2007, Vol 25, Num 34, pp 5531-5531, issn 0732-183X, 1 p.Article

The International Society of Gastrointestinal Oncology proceedings from the first annual conferenceAJANI, Jaffer A.Seminars in oncology. 2005, Vol 32, Num 6, issn 0093-7754, 138 p., SUP9Conference Proceedings

Gemcitabine-based combination treatment of pancreatic cancerHEINEMANN, Volker.Seminars in oncology. 2002, Vol 29, Num 1, pp 25-35, issn 0093-7754, SUP3Article

Current and future perspectives in advanced bladder cancer: Is there a new standard?VON DER MAASE, Hans.Seminars in oncology. 2002, Vol 29, Num 1, pp 3-14, issn 0093-7754, SUP3Article

Doubts About Whether Docetaxel, Cisplatin, Plus Fluorouracil Has Any Benefit in Advanced Gastric CancerHAINES, Ian E; AJANI, Jaffer A.Journal of clinical oncology. 2007, Vol 25, Num 34, pp 5528-5530, issn 0732-183X, 3 p.Article

Adjuvant chemotherapy of stage III colon cancerBENSON, Al B.Seminars in oncology. 2005, Vol 32, Num 6, issn 0093-7754, S74-S77, SUP9Conference Paper

Gemcitabine doublets in advanced urothelial cancerSTADLER, Walter M.Seminars in oncology. 2002, Vol 29, Num 1, pp 15-19, issn 0093-7754, SUP3Article

Preoperative and adjuvant therapies for upper qastrointestinal cancersVARADHACHARY, Gauri R; AJANI, Jaffer A.Expert review of anticancer therapy. 2005, Vol 5, Num 4, pp 719-725, issn 1473-7140, 7 p.Article

ICACT/ISGIO European Gastrointestinal Conference 2005: Research-Driven Clinical Approaches to Gastrointestinal OncologyAJANI, Jaffer A.Seminars in oncology. 2005, Vol 32, Num 6, issn 0093-7754, 42 p., SUP8Conference Proceedings

Is resection necessary for esophageal carcinoma?PUTNAM, Joe B.Seminars in oncology. 2005, Vol 32, Num 6, issn 0093-7754, S21-S24, SUP9Conference Paper

Preoperative chemoradiation for pancreatic cancerEVANS, Douglas B.Seminars in oncology. 2005, Vol 32, Num 6, issn 0093-7754, S25-S29, SUP9Conference Paper

Transplantation for liver tumorsBELGHITI, Jacques.Seminars in oncology. 2005, Vol 32, Num 6, pp S29-S32, issn 0093-7754, SUP8Conference Paper

Research-driven clinical approaches in gastrointestinal oncology, Paris, February 1-2, 2006AJANI, Jaffer A.Seminars in oncology. 2007, Vol 34, Num 2, issn 0093-7754, 46 p., SUP1Conference Proceedings

Variation in the human genome and the inherited basis of common diseaseGABRIEL, Stacey.Seminars in oncology. 2006, Vol 33, Num 6, issn 0093-7754, S46-S49, SUP11Conference Paper

Molecular mechanisms and targeting of colorectal cancerVANHOEFER, Udo.Seminars in oncology. 2005, Vol 32, Num 6, pp S7-S10, issn 0093-7754, SUP8Conference Paper

Clinical trials with tumor antigen genetically modified dendritic cells : Gene therapy of cancerRIBAS, Antoni.Seminars in oncology. 2005, Vol 32, Num 6, pp 556-562, issn 0093-7754, 7 p., SUP9Conference Paper

Management of Barrett's esophagus : Cases and questionsBRESALIER, Robert.Seminars in oncology. 2005, Vol 32, Num 6, issn 0093-7754, S2-S5, SUP9Conference Paper

Radiotherapy in the adjuvant management of pancreatic adenocarcinomaABRAMS, Ross A.Seminars in oncology. 2005, Vol 32, Num 6, issn 0093-7754, S30-S32, SUP9Conference Paper

The role of bevacizumab as first-line therapy for colon cancerMARSHALL, John.Seminars in oncology. 2005, Vol 32, Num 6, issn 0093-7754, S43-S47, SUP9Conference Paper

Therapeutic response to octreotide in patients with refractory CPT-11 induced diarrheaPRO, Barbara; LOZANO, Richard; AJANI, Jaffer A et al.Investigational new drugs. 2001, Vol 19, Num 4, pp 341-343, issn 0167-6997Article

Impact of Chemotherapy on Quality of Life in Patients With Metastatic Esophagogastric CancerAL-BATRAN, Salah-Eddin; AJANI, Jaffer A.Cancer. 2010, Vol 116, Num 11, pp 2511-2518, issn 0008-543X, 8 p.Article

Future Developments in Esophageal Cancer ResearchAJANI, Jaffer A.Gastroenterology clinics of North America. 2009, Vol 38, Num 1, issn 0889-8553, x, 183-188 [7 p.]Article

  • Page / 9